vs

Side-by-side financial comparison of LandBridge Co LLC (LB) and Schrodinger, Inc. (SDGR). Click either name above to swap in a different company.

Schrodinger, Inc. is the larger business by last-quarter revenue ($87.2M vs $56.8M, roughly 1.5× LandBridge Co LLC). Schrodinger, Inc. runs the higher net margin — 37.3% vs 14.2%, a 23.1% gap on every dollar of revenue. On growth, LandBridge Co LLC posted the faster year-over-year revenue change (55.6% vs -1.2%). LandBridge Co LLC produced more free cash flow last quarter ($122.0M vs $-16.1M). Over the past eight quarters, LandBridge Co LLC's revenue compounded faster (72.8% CAGR vs 54.4%).

Schrodinger, Inc. is a leading provider of advanced computational chemistry and physics software platforms, along with related consulting services, focused on accelerating drug discovery and novel materials development. Its solutions are adopted by biopharmaceutical companies, chemical manufacturers, academic research institutions and government entities across North America, Europe and Asia Pacific to cut R&D costs and shorten innovation cycles.

LB vs SDGR — Head-to-Head

Bigger by revenue
SDGR
SDGR
1.5× larger
SDGR
$87.2M
$56.8M
LB
Growing faster (revenue YoY)
LB
LB
+56.8% gap
LB
55.6%
-1.2%
SDGR
Higher net margin
SDGR
SDGR
23.1% more per $
SDGR
37.3%
14.2%
LB
More free cash flow
LB
LB
$138.2M more FCF
LB
$122.0M
$-16.1M
SDGR
Faster 2-yr revenue CAGR
LB
LB
Annualised
LB
72.8%
54.4%
SDGR

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
LB
LB
SDGR
SDGR
Revenue
$56.8M
$87.2M
Net Profit
$8.1M
$32.5M
Gross Margin
65.7%
Operating Margin
60.0%
-19.7%
Net Margin
14.2%
37.3%
Revenue YoY
55.6%
-1.2%
Net Profit YoY
-83.7%
180.8%
EPS (diluted)
$0.24
$0.45

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
LB
LB
SDGR
SDGR
Q4 25
$56.8M
$87.2M
Q3 25
$50.8M
$54.3M
Q2 25
$47.5M
$54.8M
Q1 25
$44.0M
$59.6M
Q4 24
$36.5M
$88.3M
Q3 24
$28.5M
$35.3M
Q2 24
$26.0M
$47.3M
Q1 24
$19.0M
$36.6M
Net Profit
LB
LB
SDGR
SDGR
Q4 25
$8.1M
$32.5M
Q3 25
$8.1M
$-32.8M
Q2 25
$7.5M
$-43.2M
Q1 25
$6.5M
$-59.8M
Q4 24
$49.3M
$-40.2M
Q3 24
$2.7M
$-38.1M
Q2 24
$-57.7M
$-54.0M
Q1 24
$10.8M
$-54.7M
Gross Margin
LB
LB
SDGR
SDGR
Q4 25
65.7%
Q3 25
51.6%
Q2 25
47.8%
Q1 25
52.3%
Q4 24
72.6%
Q3 24
50.2%
Q2 24
66.2%
Q1 24
51.6%
Operating Margin
LB
LB
SDGR
SDGR
Q4 25
60.0%
-19.7%
Q3 25
60.8%
-84.6%
Q2 25
60.0%
-96.6%
Q1 25
57.0%
-85.5%
Q4 24
49.4%
-23.5%
Q3 24
11.2%
-193.9%
Q2 24
-197.4%
-111.4%
Q1 24
71.1%
-184.3%
Net Margin
LB
LB
SDGR
SDGR
Q4 25
14.2%
37.3%
Q3 25
15.9%
-60.4%
Q2 25
15.8%
-78.8%
Q1 25
14.7%
-100.4%
Q4 24
135.2%
-45.5%
Q3 24
9.3%
-108.1%
Q2 24
-222.1%
-114.2%
Q1 24
56.7%
-149.5%
EPS (diluted)
LB
LB
SDGR
SDGR
Q4 25
$0.24
$0.45
Q3 25
$0.26
$-0.45
Q2 25
$0.24
$-0.59
Q1 25
$0.20
$-0.82
Q4 24
$-0.55
Q3 24
$-0.04
$-0.52
Q2 24
$-0.74
Q1 24
$-0.76

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
LB
LB
SDGR
SDGR
Cash + ST InvestmentsLiquidity on hand
$30.7M
$395.5M
Total DebtLower is stronger
$570.7M
Stockholders' EquityBook value
$340.3M
$364.1M
Total Assets
$1.4B
$726.2M
Debt / EquityLower = less leverage
1.68×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
LB
LB
SDGR
SDGR
Q4 25
$30.7M
$395.5M
Q3 25
$28.3M
$391.2M
Q2 25
$20.3M
$450.2M
Q1 25
$14.9M
$500.3M
Q4 24
$37.0M
$352.1M
Q3 24
$14.4M
$388.7M
Q2 24
$24.6M
$377.3M
Q1 24
$431.1M
Total Debt
LB
LB
SDGR
SDGR
Q4 25
$570.7M
Q3 25
$366.1M
Q2 25
$370.9M
Q1 25
$375.5M
Q4 24
$385.5M
Q3 24
$242.4M
Q2 24
$360.8M
Q1 24
Stockholders' Equity
LB
LB
SDGR
SDGR
Q4 25
$340.3M
$364.1M
Q3 25
$272.0M
$321.4M
Q2 25
$266.4M
$342.9M
Q1 25
$217.0M
$373.5M
Q4 24
$211.8M
$421.4M
Q3 24
$97.2M
$449.4M
Q2 24
$296.4M
$474.0M
Q1 24
$162.3M
$513.7M
Total Assets
LB
LB
SDGR
SDGR
Q4 25
$1.4B
$726.2M
Q3 25
$1.1B
$653.7M
Q2 25
$1.1B
$688.2M
Q1 25
$1.0B
$743.0M
Q4 24
$1.0B
$823.2M
Q3 24
$689.9M
$669.3M
Q2 24
$710.5M
$688.4M
Q1 24
$737.8M
Debt / Equity
LB
LB
SDGR
SDGR
Q4 25
1.68×
Q3 25
1.35×
Q2 25
1.39×
Q1 25
1.73×
Q4 24
1.82×
Q3 24
2.49×
Q2 24
1.22×
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
LB
LB
SDGR
SDGR
Operating Cash FlowLast quarter
$126.3M
$-16.1M
Free Cash FlowOCF − Capex
$122.0M
$-16.1M
FCF MarginFCF / Revenue
214.9%
-18.5%
Capex IntensityCapex / Revenue
7.5%
0.0%
Cash ConversionOCF / Net Profit
15.68×
-0.50×
TTM Free Cash FlowTrailing 4 quarters
$207.7M
$12.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
LB
LB
SDGR
SDGR
Q4 25
$126.3M
$-16.1M
Q3 25
$34.9M
$-61.9M
Q2 25
$37.3M
$-52.2M
Q1 25
$15.9M
$144.1M
Q4 24
$67.6M
$-31.1M
Q3 24
$7.5M
$-33.3M
Q2 24
$16.0M
$-53.7M
Q1 24
$17.2M
$-39.3M
Free Cash Flow
LB
LB
SDGR
SDGR
Q4 25
$122.0M
$-16.1M
Q3 25
$33.7M
$-62.4M
Q2 25
$36.1M
$-52.5M
Q1 25
$15.8M
$143.5M
Q4 24
$66.7M
$-32.0M
Q3 24
$7.1M
$-34.6M
Q2 24
$15.7M
$-54.7M
Q1 24
$17.1M
$-43.4M
FCF Margin
LB
LB
SDGR
SDGR
Q4 25
214.9%
-18.5%
Q3 25
66.3%
-114.8%
Q2 25
75.9%
-95.9%
Q1 25
36.0%
240.9%
Q4 24
182.6%
-36.2%
Q3 24
25.1%
-98.0%
Q2 24
60.4%
-115.6%
Q1 24
90.1%
-118.5%
Capex Intensity
LB
LB
SDGR
SDGR
Q4 25
7.5%
0.0%
Q3 25
2.3%
0.9%
Q2 25
2.6%
0.6%
Q1 25
0.2%
1.0%
Q4 24
2.7%
1.0%
Q3 24
1.1%
3.8%
Q2 24
1.4%
2.1%
Q1 24
0.5%
11.2%
Cash Conversion
LB
LB
SDGR
SDGR
Q4 25
15.68×
-0.50×
Q3 25
4.31×
Q2 25
4.98×
Q1 25
2.46×
Q4 24
1.37×
Q3 24
2.80×
Q2 24
Q1 24
1.60×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

LB
LB

Segment breakdown not available.

SDGR
SDGR

On Premise Software$44.4M51%
Drug Discovery Services$17.6M20%
Hosted Software$11.5M13%
Maintenance$6.9M8%
Professional Services$3.8M4%
July2024Agreement With Bill Melinda Gates Foundation$2.7M3%

Related Comparisons